Bluejay Diagnostics (BJDX) Long-Term Deferred Tax (2020 - 2022)

Bluejay Diagnostics' Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $2.7 million for Q4 2022.

• In Q4 2022, Long-Term Deferred Tax rose 200.0% year-over-year to $2.7 million; the TTM figure through Dec 2022 stood at $2.7 million (up 200.0% YoY), while the FY2022 annual figure was $2.7 million, up 200.0% from the prior year.
• Long-Term Deferred Tax came in at $2.7 million for Q4 2022 at Bluejay Diagnostics, up from $900000.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.7 million in Q4 2022 to a low of $900000.0 in Q4 2021.
• A 3-year average of $1.6 million and a median of $1.1 million in 2020 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax slipped 15.9% in 2021 and soared 200.0% in 2022, its largest moves.
• Bluejay Diagnostics' Long-Term Deferred Tax stood at $1.1 million in 2020, then fell by 15.9% to $900000.0 in 2021, then jumped by 200.0% to $2.7 million in 2022.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $2.7 million, $900000.0, and $1.1 million for Q4 2022, Q4 2021, and Q4 2020 respectively.

Peer Comparison